Camden National Corporation
NASDAQ:CACBanks - Regional
+$0.02 today
- Market cap
- $981.28M
- Beta
- 0.56
- P/E (TTM)
- 10.9
- EPS (TTM)
- $4.70
- Dividend yield
- 3.27%
Volume 0.06M
Average 0.10M
CAC EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Camden National CorporationNASDAQ: CAC
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $5.47M fell 40.3% year over year, behind the +43.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 83.3% from the prior quarter. Over 3 fiscal years it compounded at +4.1% a year.
Context
- EBITDA amounted to 24.9% of revenue in FY2025, up 1.0 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $123.19M (+34.6%) for the fiscal year ending Dec 2026, a step up from the +32.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $5.47M-83.3% QoQ
- Last fiscal yearDec 2025
- $91.54M+32.0% YoY
- LTMMar 2026
- $87.86M+43.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -40.3% | +32.2% | +72.5 pp |
| 1 year | +32.0% | +34.6% | +2.5 pp |
| 3-year CAGR | +4.1% | +14.2% | +10.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 91.54M USD
- Year-over-year change
- +32.0%
- 4-year CAGR
- +0.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 91.54M | +32.0% |
| FY2024 | 2024-12-31 | 69.33M | +19.9% |
| FY2023 | 2023-12-31 | 57.8M | -28.8% |
| FY2022 | 2022-12-31 | 81.16M | -10.8% |
| FY2021 | 2021-12-31 | 91M | — |
EBITDA vs competitors
How CAC compares with its peers on the latest reported figures
- CAC's LTM Mar 2026 EBITDA of $87.86M is the 3rd highest of the 11 companies compared; the peer median is $30.5M.
- Its year-over-year change of +43.6% is the 5th highest of 11, against a peer median of +41.0%.
- EBITDA amounts to 24.6% of revenue for CAC, versus a peer median of 24.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $101.11M | +35.4% | +3.3% | 23.2% | |
| LTM Mar 2026 | $88.01M | +10.4% | +22.3% | 32.0% | |
| LTM Mar 2026 | $87.86M | +43.6% | +4.1% | 24.6% | |
| LTM Mar 2026 | $70.9M | +319.7% | -9.1% | 18.8% | |
| LTM Mar 2026 | $70.61M | +101.4% | +3.0% | 35.7% | |
| LTM Mar 2026 | $30.69M | +239.8% | +5.9% | 26.4% | |
| LTM Mar 2026 | $30.3M | +39.3% | -0.7% | 14.7% | |
| LTM Mar 2026 | $28.34M | +42.6% | -1.0% | 22.8% | |
| LTM Mar 2026 | $26.9M | +2.6% | -5.8% | 32.4% | |
| LTM Mar 2026 | $23.77M | -32.7% | -3.7% | 14.4% | |
| LTM Mar 2026 | $22.84M | +96.8% | -13.9% | 26.5% | |
| Peer median (excluding CAC) | $30.5M | +41.0% | -0.8% | 24.8% | |
Competitors are the stored peer set for CAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 193.91M | 208.89M | 250.32M | 289.72M | 367.34M |
| Cost of Revenue | 7.86M | 29.59M | 94.25M | 117.61M | 136.72M |
| Gross Profit | 186.05M | 179.29M | 156.07M | 172.11M | 230.62M |
| Gross Margin | 95.9% | 85.8% | 62.3% | 59.4% | 62.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 61.01M | 62.02M | 60.01M | 64.07M | 59.72M |
| Operating Expenses | 99.41M | 102.25M | 102.24M | 106.65M | 149M |
| Depreciation & Amortization | 4.36M | 4.12M | 3.96M | 3.87M | 9.92M |
| EBITDA | 91M | 81.16M | 57.8M | 69.33M | 91.54M |
| EBITDA Margin | 46.9% | 38.9% | 23.1% | 23.9% | 24.9% |
| Operating Income | 86.64M | 77.05M | 53.84M | 65.46M | 81.62M |
| Operating Margin | 44.7% | 36.9% | 21.5% | 22.6% | 22.2% |
| Interest Income | 148.48M | 172.79M | 226.25M | 249.56M | 320.66M |
| Interest Expense | 11.05M | 25.09M | 93.98M | 117.1M | 117.4M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (2.97M) |
| Income Before Tax | 86.64M | 77.05M | 53.84M | 65.46M | 78.66M |
| Pre-Tax Margin | 44.7% | 36.9% | 21.5% | 22.6% | 21.4% |
| Income Tax Expense | 17.63M | 15.61M | 10.45M | 12.46M | 13.5M |
| Net Income | 69.01M | 61.44M | 43.38M | 53M | 65.16M |
| Net Margin | 35.6% | 29.4% | 17.3% | 18.3% | 17.7% |
| EPS (Basic) | 4.62 | 4.18 | 2.98 | 3.63 | 3.85 |
| EPS (Diluted) | 4.60 | 4.17 | 2.97 | 3.62 | 3.84 |
| Weighted Avg Shares | 14.9M | 14.64M | 14.56M | 14.58M | 16.84M |
| Weighted Avg Shares (Diluted) | 14.97M | 14.7M | 14.61M | 14.63M | 16.96M |
Camden National Corporation
NASDAQ:CAC
Intrinsic Alpha fair value
Locked
Current Price
$58.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.